- Global Pharma News & Resources

Insights on the Bone Grafts & Substitutes Global Market to 2027 - Increasing Demand from Orthopedic Surgeries Presents Opportunities -

DUBLIN--(BUSINESS WIRE)--The "Bone Grafts & Substitutes Market Research Report by Product (Allografts and Synthetic), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Bone Grafts & Substitutes Market size was estimated at USD 2,956.08 million in 2021, USD 3,143.63 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.52% to reach USD 4,318.55 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bone Grafts & Substitutes Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bone Grafts & Substitutes Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bone Grafts & Substitutes Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bone Grafts & Substitutes Market?

4. What is the competitive strategic window for opportunities in the Global Bone Grafts & Substitutes Market?

5. What are the technology trends and regulatory frameworks in the Global Bone Grafts & Substitutes Market?

6. What is the market share of the leading vendors in the Global Bone Grafts & Substitutes Market?

7. What modes and strategic moves are considered suitable for entering the Global Bone Grafts & Substitutes Market?

Market Dynamics


  • Growing occurrences of bone and joint disorders
  • Potential demand for dental bone grafts and substitutes globally
  • Introduction of biocompatible and tough multi-layered bone graft in the treatment of large bone defects


  • Strict regulatory mandates in the use of medical devices


  • Increasing demand from orthopedic surgeries
  • Emerging preference for minimally invasive treatment


  • Difficulty in pricing due to pressure from competitors

Companies Mentioned

  • AlloSource, Inc.
  • Anand Mediproducts Pvt Ltd
  • Arthrex, Inc.
  • Baxter International Inc
  • Biobank
  • Biohorizons Implant Systems, Inc
  • DePuy Synthes, Inc
  • Geistlich Pharma AG
  • Integra LifeSciences Holdings Corporation
  • Keramat, s.l.u.
  • Medtronic PLC
  • Musculoskeletal Transplant Foundation
  • Nobel Biocare.
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
  • OST Developpement
  • RTI Surgical, Inc.
  • SeaSpine Holdings
  • SigmaGraft Inc.
  • Smith & Nephew, PLC
  • Stryker Corporation
  • TBF Tissue Engineering
  • TiGenix
  • Wright Medical Group N.V.
  • Zimmer Biomet

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 06-Jun-2022